Keyphrases
Molecular Design
100%
Fungi
100%
Infection Treatment
100%
Molecular Targets
100%
New Drugs
100%
Antioxidant Activity
50%
Betanin
50%
Epimer
50%
Dynamic Density Functional Theory
50%
Betanidin
50%
Molecular Dynamics
50%
Infrared Spectroscopy
50%
Shape Theory
50%
Fusarium Oxysporum
42%
Histoplasma Capsulatum
42%
New Drug Targets
35%
Xanthine Oxidase
33%
Molecular Docking
33%
Orthologs
28%
Therapeutic Target
23%
Putative Drug Targets
21%
Active Sites
21%
New Inhibitors
21%
Human Proteins
21%
Orthologous Proteins
21%
Pathogenic Fungi
21%
PDE
16%
Molecular Simulation
16%
Free Radical Scavenger
16%
Technique Analysis
16%
Geometrical Arrangement
16%
SPLET Mechanism
16%
B3LYP
16%
Hydrogen Atom
16%
Parallelization
16%
New Proposal
16%
Infrared Spectra
16%
Fungal Proteins
14%
Specific Inhibitor
14%
New Targets
14%
Potential Inhibitors
14%
Microorganisms
14%
Biomolecular Target
7%
Disease Targets
7%
Binding Affinity Prediction
7%
Human Health
7%
Expected Outcomes
7%
Two-species
7%
Topological Difference
7%
Chemical Difference
7%
Human Host
7%
High Similarity
7%
Metabolic Function
7%
Protein Ortholog
7%
Antifungal Drugs
7%
Adverse Effects
7%
Intensive Phase
7%
Unique Proteins
7%
Computational Simulation
7%
Cross-reactivity
7%
Chemical Properties
7%
Cancer Treatment
7%
Fungal Infection
7%
High Performance
7%
International Congresses
7%
Solid Support
7%
Approved Drugs
7%
Phosphoinositide 3-kinase (PI3K)
7%
Proteinase Inhibitor
7%
Computational Evaluation
7%
Human Nature
7%
Amino Acid Variation
7%
Emerging Threats
7%
Genome Sequencing
7%
Design Space
7%
Pharmacology, Toxicology and Pharmaceutical Science
Molecular Target
100%
Infection
100%
Ajellomyces capsulatus
100%
Fusarium oxysporum
50%
Infectious Agent
50%
Infrared Spectroscopy
50%
Antioxidant Capacity
50%
Fusarium oxysporum
50%
Xanthine Oxidase
33%
Fungal Protein
33%
Amino Acid
16%
Antifungal Agent
16%
Malignant Neoplasm
16%
Phosphatidylinositol 3 Kinase
16%
Protein Inhibitor
16%
Mycosis
16%
Microorganism
16%
Hydrogen
16%
Scavenger
16%
Microorganism
16%
Disease
8%
Adverse Event
8%
Diseases
8%